Clinical Trial

Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG

Completed
View on ClinicalTrials.gov →
Summary
This study aimed to examine whether baseline depressive tendency independently predicts post-counseling clinical outcomes in patients with thymoma-associated MG. This single-group pre-post exploratory pilot study enrolled patients with thymoma-associated MG who received eight sessions of Gestalt-oriented psychological counseling. Depressive tendency was defined as a baseline Patient Health Question-naire-9 (PHQ-9) score ≥10. Clinical outcomes, including the Myasthenia Gravis Activities of Daily Living scale (MG-ADL), Myasthenia Gravis Quality of Life 15-item scale (MG-QoL15), and mental BMI (mBMI), were assessed before and after the intervention. Multivariable regression analyses were performed to evaluate whether baseline clinical severity independently predicted post-intervention outcomes after sequential adjustment for baseline scores, age, and sex.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-11.
Trial Details
NCT Number NCT07649187
Lead Sponsor Ming-Hsing Chang
Collaborators: Shin Kong Wu Ho-Su Memorial Hospital
Conditions Myasthenia Gravis, Depression, Thymoma, Depression and Quality of Life, Quality of Life, Activities of Daily Living
Enrollment 19 participants
Start Date 2024-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-17